$80,000 of MASIMO CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology and telehealth Medicare coverage Issues related to intellectual property and anti-competitive behavior in the medical device supply chain Issues related to increased tariffs"
You can find more data on corporate lobbying on Quiver Quantitative.
MASI Hedge Fund Activity
We have seen 167 institutional investors add shares of MASI stock to their portfolio, and 166 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,970,883 shares (+41.2%) to their portfolio in Q3 2024, for an estimated $262,777,830
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,206,984 shares (-99.1%) from their portfolio in Q3 2024, for an estimated $160,927,176
- MILLENNIUM MANAGEMENT LLC removed 724,490 shares (-96.1%) from their portfolio in Q3 2024, for an estimated $96,596,251
- POINT72 ASSET MANAGEMENT, L.P. removed 677,677 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $90,354,674
- BLACKROCK, INC. removed 528,970 shares (-5.7%) from their portfolio in Q3 2024, for an estimated $70,527,570
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 372,137 shares (+32.2%) to their portfolio in Q3 2024, for an estimated $49,617,026
- ALYESKA INVESTMENT GROUP, L.P. added 314,196 shares (+72.9%) to their portfolio in Q3 2024, for an estimated $41,891,752
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
